Chinese Journal of Hepatology 2006 Issue 9 Current status and prospectives in research on liver failure

Current status and prospectives in research on liver failure
ZHANG Ding-feng

..............page:641-642

Diagnostic and treatment guidelines for liver failure Liver Failure and
Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association;Severe Liver Diseases and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association

..............page:643-646

Survival analysis on liver failure patients treated with an artificial liver support system
ZHANG Jing;DUAN Zhong-ping;HE Jin-qiu;ZHANG Lun-li;CHEN Shi-bin;ZOU Chun-yi;XIN Shao-jie;WU Wen-fang;MA Bin-rong;CHEN Yu;KONG Ming;LIU Mei;HAN Da-kang

..............page:647-651

Combined non-biological artificial liver in treatment of late stage chronic severe hepatitis
JIN Jie;YE Wei-jiang;HUANG Jin-song;YU Zhe;YU Hai-yan

..............page:652-654

An analysis of the relationship between HBV DNA and HBeAg expression and mortality in 799 severe hepatitis patients
WANG Rong-bing;ZHOU Gui-qin;JIANG Yu-yong;SUN Feng-xia;WU Yun-zhong;SUN Jing-yuan;MENG Pei-pei;NIU Si-meng

..............page:655-657

Detection of HBV specific cytotoxic lymphocytes responses in severe hepatitis B patients using MHC-peptide tetramer flow cytometry
CHEN Yu;WU Wei;LI Lan-juan

..............page:658-661

Inhibition of HBV replication and antigen expression by RNA interference against different targets
ZHANG Bing-qiang;HUANG Ying;TANG Ni;WU Ying;ZHANG Jun;CHEN Wei-xian;HE TONG-chuan;HUANG Ai-long

..............page:662-665

The construction and primary screening of a phage display library of HCV C and E1 genes evolved with an artificial pattern
ZHAO Fu-tao;JIA Zhan-sheng;LI Jin-ge;WANG Chun-yu;WEI Xin;LI Guang-yu;BAI Xue-fan

..............page:666-669

Adenovirus vector expressing MDA-7/IL-24 selectively induces growth arrests and apoptosis in human hepatocellular carcinoma cell lines independent of the state of p53 gene
XUE Xin-bo;ZHENG Jian-wei;WANG Cong-jun;CHEN Kun;HU Hui-yi;HU Hui;YU Yuan;WU Zai-de

..............page:670-675

A relationship between cyclooxygenase-2 expression and tumor angiogenesis in experimental rat liver carcinogenesis
XIE Ying-hui;YUAN Meng-biao

..............page:676-679

Clinical application of artificial livers
DUAN Zhong-ping;ZHENG Su-jun

..............page:680-681

Comments on the current status of the clinical application of artificial livers
XIE Qing;XIANG Xiao-gang

..............page:682-684

Problems and strategies in the application of artificial livers
LEI Bing-jun

..............page:685

Current status in the use of artificial liver support systems for treating fulminant hepatic failure
LU Qing

..............page:686-687

To evaluate the effects of orthotopic liver transplantation in the treatment of fulminating hepatitis
ZUO Huai-quan;YAN Lü-nan;LI Bo;ZENG Yong;WEN Tian-fu;ZHAO Ji-chun

..............page:688-690

zhong hua gan zang bing za zhi zheng ding zheng gao tong zhi

..............page:709

High mobility group box 1 protein and its effect on liver injury complicated with endotoxemia
ZHAO Zhong-fu;HAN De-wu

..............page:718-720

Insulin-like growth factor binding proteins and endotoxin in liver fibrosis
LIU Li-xin;TIAN Xiao-xia;HAN De-wu

..............page:715-717

A case of angiosarcoma developed from liver hamartomas
WANG Jian;LI Qiang;SUN Yan;CUI Yun-long

..............page:717

Severe viral hepatitis complicated with pleural aspergillus infection treated with itraconazole and amphotericin B
WANG Hui-fen;SU Hai-bin;LI Han-wei;JIN Bo;CHEN Jing;ZHANG Ai-min

..............page:690-691

A case of primary hepatic amyloidosis with factor X deficiency
DONG Man-ku;CUI Yan;XIA hu;ZHOU Li-yan;SUN Wei-guo;LI Cheng-lin;ZHANG Hong-wen;JI Min;LI Xiao-ou

..............page:684

Effect of saikosaponins-d on cyciooxygenase-2 expression of human hepatocellular carcinoma cell line SMMC-7721
HE Shui-xiang;LUO Jin-yan;ZHAO Gang;XU Jun-li;WANG Yan-li;FU Han;DONG Lei

..............page:712-714

Ganglioside GD3 enhances the anti-tumor effect of doxorubicin on hepatoma cells
WANG Jian-hong;HUANG Zhi-ming;WU Jian-sheng;CHEN Xiang-rong;JIN Shu-qing;HUANG Qing-ke;WANG Dan

..............page:710-711

The effect of radiofrequency ablation combined with arsenites on rabbit liver VX2 tumors
ZHANG Meng-hui;KONG Xian-bing;WANG Qiao-ling;HUANG Xiao-ling;WANG Hui;GUO Ai-hong

..............page:707-709

The significance of anti-endothelial cell antibody expression in rat liver fibrosis treated with estrogen
DENG Jing-yu;HE Sheng;CHEN Bo

..............page:705-707

Effect of rosiglitazone on metalloproteinase tissue inhibitor-1 in CCl4 induced liver fibrosis in rats
ZHOU Xi-han;LI Ming-gui;L(U) Xiao-hong;WU Xiang-yue;YU Jie-ping

..............page:703-704

Preventive effects of pioglitazone on rat fatty liver induced by a high fat diet
XU Ping;LI You-ming;YU Chao-hui;XU Lei;XU Gen-yun

..............page:701-702

Expression and significance of transforming growth factor β receptor Ⅰ and platelet derived growth factor and their receptors in liver tissues of patients with non-alcoholic fatty liver
XIANG Ming-que;YUAN Xiao-ying;ZHANG Pei-lin;WANG Xu-dong;LI Zhi-quan

..............page:698-700

Plasma proteomic pattern predicts the stages of rat liver fibrosis
ZHANG Qi-sheng;John M Luk

..............page:695-697

Effect of TGF β 1 vaccine on the expression of MMP-2 and TISP-2 in rats with liver fibrosis
LU Ming-qin;CHEN Yong-ping;PAN Chen-wei;WANG Xiao-dong

..............page:692-694